ArticleCancer science2025

Comparison of the Efficacy of Different First-Line Therapies for EGFR L858R-Mutated NSCLC Patients With Brain Metastases.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.